e-learning
resources
Munich 2006
Monday 04.09.2006
Various parenchymal lung diseases and pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Successful artocoronary bypass grafting in a patient with severe idiopathic pulmonary arterial hypertension: use of intravenous treprostinil
C. Geltner, S. Ruescher, M. Stein, M. Kroell, E. Ruttmann, L. C. Mueller (Natters, Innsbruck, Austria)
Source:
Annual Congress 2006 - Various parenchymal lung diseases and pulmonary hypertension
Session:
Various parenchymal lung diseases and pulmonary hypertension
Session type:
Poster Discussion
Number:
2279
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Geltner, S. Ruescher, M. Stein, M. Kroell, E. Ruttmann, L. C. Mueller (Natters, Innsbruck, Austria). Successful artocoronary bypass grafting in a patient with severe idiopathic pulmonary arterial hypertension: use of intravenous treprostinil. Eur Respir J 2006; 28: Suppl. 50, 2279
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Influence of discontinuation of medication after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 595-600
Year: 2004
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
Source: Eur Respir J 2006; 28: 1195-1203
Year: 2006
Direct oral anticoagulant use and thrombus detection in patients with chronic thromboembolic pulmonary hypertension referred for pulmonary thromboendarterectomy
Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Year: 2019
Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018
Broviac catheter complications of intravenous epoprostenol therapy in patients with pulmonary arterial hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 636s
Year: 2004
Effects of percutaneous transluminal pulmonary angioplasty on respiratory functions in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015
Balloon pulmonary angioplasty in a patient with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2014; 23: 393-395
Year: 2014
Good outcomes following elective lower limb orthopaedic surgery in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
Antecubital venous access for balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Experience with subcutaneous treprostinil in children with pulmonary arterial hypertension
Source: International Congress 2017 – NICU/ PICU: evaluating short- and long-term ventilatory management
Year: 2017
Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Severe pulmonary arterial hypertension: treatment options and the bridge to transplantation
Source: Eur Respir Rev 2014; 23: 488-497
Year: 2014
Low dose intravenous iloprost therapy in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 426s
Year: 2006
Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience
Source: Eur Respir J, 49 (6) 1602409; 10.1183/13993003.02409-2016
Year: 2017
Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2015; 24: 263-271
Year: 2015
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010
Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence
Source: Eur Respir J 2009; 34: 7-9
Year: 2009
Long-term safety and outcome of subcutaneous and intravenous treprostinil in patients with severe chronic pulmonary hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept